BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Merino D, San Segundo D, Medina JM, Rodrigo E, Asensio E, Irure J, Fernández-Fresnedo G, Arias MA, López-Hoyos M. Different in vitro proliferation and cytokine-production inhibition of memory T-cell subsets after calcineurin and mammalian target of rapamycin inhibitors treatment. Immunology 2016;148:206-15. [PMID: 26931075 DOI: 10.1111/imm.12603] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Grenzi PC, Campos ÉF, Tedesco-Silva H Jr, Felipe CR, Soares MF, Medina-Pestana J, Hansen HP, Gerbase-DeLima M. Influence of immunosuppressive drugs on the CD30 molecule in kidney transplanted patients. Hum Immunol 2018;79:550-7. [PMID: 29656112 DOI: 10.1016/j.humimm.2018.04.002] [Reference Citation Analysis]
2 Franceschini E, De Biasi S, Digaetano M, Bianchini E, Lo Tartaro D, Gibellini L, Menozzi M, Zona S, Tarantino G, Nasi M, Codeluppi M, Guaraldi G, Magistri P, Di Benedetto F, Pinti M, Mussini C, Cossarizza A. Efficient T-Cell Compartment in HIV-Positive Patients Receiving Orthotopic Liver Transplant and Immunosuppressive Therapy. J Infect Dis 2021;223:482-93. [PMID: 32620016 DOI: 10.1093/infdis/jiaa395] [Reference Citation Analysis]
3 Leino AD, Pai MP. Maintenance Immunosuppression in Solid Organ Transplantation: Integrating Novel Pharmacodynamic Biomarkers to Inform Calcineurin Inhibitor Dose Selection. Clin Pharmacokinet 2020;59:1317-34. [PMID: 32720300 DOI: 10.1007/s40262-020-00923-w] [Reference Citation Analysis]
4 Liu Q, Sun Z, Chen L. Memory T cells: strategies for optimizing tumor immunotherapy. Protein Cell 2020;11:549-64. [PMID: 32221812 DOI: 10.1007/s13238-020-00707-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
5 Okimoto A, Yamamoto R, Hirose J, Shimatani K, Koshika T, Maeda M, Hattori K, Morokata T. ASP1126, a Novel Sphingosine-1-Phosphate-Selective Agonist With a Favorable Safety Profile, Prolongs Allograft Survival in Rats and Nonhuman Primates in Combination With Tacrolimus With a Broad Safety Margin for Bradycardia. Transplant Proc 2019;51:2081-98. [PMID: 31399186 DOI: 10.1016/j.transproceed.2019.05.012] [Reference Citation Analysis]
6 Wang F, Wang S, He B, Liu H, Wang X, Li C, Peng P, Zhao J, Zang Y. Immunotherapeutic strategy based on anti-OX40L and low dose of IL-2 to prolong graft survival in sensitized mice by inducing the generation of CD4+ and CD8+ Tregs. Int Immunopharmacol 2021;97:107663. [PMID: 33887578 DOI: 10.1016/j.intimp.2021.107663] [Reference Citation Analysis]
7 Brunet M, van Gelder T, Åsberg A, Haufroid V, Hesselink DA, Langman L, Lemaitre F, Marquet P, Seger C, Shipkova M, Vinks A, Wallemacq P, Wieland E, Woillard JB, Barten MJ, Budde K, Colom H, Dieterlen M, Elens L, Johnson-davis KL, Kunicki PK, Macphee I, Masuda S, Mathew BS, Millán O, Mizuno T, Moes DAR, Monchaud C, Noceti O, Pawinski T, Picard N, van Schaik R, Sommerer C, Vethe NT, de Winter B, Christians U, Bergan S. Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report. Therapeutic Drug Monitoring 2019;41:261-307. [DOI: 10.1097/ftd.0000000000000640] [Cited by in Crossref: 131] [Cited by in F6Publishing: 46] [Article Influence: 43.7] [Reference Citation Analysis]
8 Rovin BH, Solomons N, Pendergraft WF, Dooley MA, Tumlin J, Romero-diaz J, Lysenko L, Navarra SV, Huizinga RB, Adzerikho I, Mikhailova E, Mitkovskaya N, Pimanov S, Soroka N, Bogov BI, Deliyska B, Ikonomov V, Tilkiyan E, Almeida R, Jimenez F, Teran F, Tchokhonelidze I, Tsiskarishvili N, Herrera Mendez M, Chavez Perez NN, Loaeza AR, Gutierrez Urena SR, Romero Diaz J, Araiza Casillas R, Madero Rovalo M, Niemczyk S, Sokalski A, Wiecek A, Klinger M, Bugrova OV, Chernykh TM, Kameneva TR, Lysenko LV, Raskina TA, Reshetko OV, Vezikova NN, Kropotina TV, Maksudova AN, Marasaev V, Dobronravov VA, Gordeev I, Essaian AM, Frolov A, Jelacic R, Jovanovic D, Mitic B, Pekovic G, Radovic M, Radunovic G, Carreira P, Diaz Gonzalez F, Fulladosa X, Ucar E, De Silva S, Herath C, Hewageegana A, Nazar ALM, Wazil A, Dudar I, Godlevska O, Korneyeva S, Vasylets V, Sydor N, Kolesnyk M, Parikh SV, Olsen N, Ginzler EM, Tumlin JA, Saxena A, Saxena R, Lafayette RA, Pendergraft WF, Podoll AS, Arrey-mensah AA, Bubb M, Grossman J, Oporta AI, Nami A, Rahman MM, Haq SA, Chan TMD, Temy MMY, Gomez HMP, Bermas J, Reyes BH, Hao LT, Roberto LC, Amante E, Navarra SV, Lanzon AE, Choe J, Kang TY, Kim YS, Lee S, Lee JS, Jun JCC, Vasudevan A, Luo S, Cheng T, Satirapoj B, Noppakun K. A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis. Kidney International 2019;95:219-31. [DOI: 10.1016/j.kint.2018.08.025] [Cited by in Crossref: 90] [Cited by in F6Publishing: 63] [Article Influence: 30.0] [Reference Citation Analysis]
9 Liu Y, Sun L, Chen W, Chuai J, Shang Y, Zhang D, Fu B, Tian H, Jiang S. Combined treatment with simvastatin and rapamycin attenuates cardiac allograft rejection through the regulation of T helper 17 and regulatory T cells. Exp Ther Med 2018;15:1941-9. [PMID: 29434788 DOI: 10.3892/etm.2017.5635] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Ren H, Cao K, Wang M. A Correlation Between Differentiation Phenotypes of Infused T Cells and Anti-Cancer Immunotherapy. Front Immunol 2021;12:745109. [PMID: 34603332 DOI: 10.3389/fimmu.2021.745109] [Reference Citation Analysis]
11 Castro-Rojas CM, Godarova A, Shi T, Hummel SA, Shields A, Tremblay S, Alloway RR, Jordan MB, Woodle ES, Hildeman DA. mTOR Inhibitor Therapy Diminishes Circulating CD8+ CD28- Effector Memory T Cells and Improves Allograft Inflammation in Belatacept-refractory Renal Allograft Rejection. Transplantation 2020;104:1058-69. [PMID: 31415033 DOI: 10.1097/TP.0000000000002917] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
12 Levitsky J, Miller J, Huang X, Gallon L, Leventhal JR, Mathew JM. Immunoregulatory Effects of Everolimus on In Vitro Alloimmune Responses. PLoS One 2016;11:e0156535. [PMID: 27275747 DOI: 10.1371/journal.pone.0156535] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]